標(biāo)題: Titlebook: Mesenchymal Stem Cell Therapy; Lucas G. Chase,Mohan C. Vemuri Book 2013 Springer Science+Business Media New York 2013 Chase.MSC.Mesenchyma [打印本頁] 作者: FLAW 時間: 2025-3-21 16:21
書目名稱Mesenchymal Stem Cell Therapy影響因子(影響力)
作者: 開花期女 時間: 2025-3-21 21:37
Mesenchymal Stromal Cells and the Repair of Cartilage Tissue,ogous chondrocytes that retain the appropriate phenotype. By contrast, the harvest and expansion of large numbers of mesenchymal stem/stromal cells (MSC) derived from tissues such as bone marrow and adipose is comparatively straightforward and has become routine in laboratories worldwide. Additional作者: CREEK 時間: 2025-3-22 02:07
Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease and Graft Failure is and were able to stop major hemorrhages in HSCT patients. MSCs produce hematopoietic growth factors and have been used clinically to support hematopoiesis and to treat graft failure. Future related areas of research include prospective randomized clinical trials, determining optimum cell source a作者: 辭職 時間: 2025-3-22 06:35 作者: 反話 時間: 2025-3-22 11:34
Mesenchymal Stem Cell Therapy for Heart Disease,therapy improved left ventricular function, induced reverse remodeling, and decreased scar size. This chapter reviews the current understanding of MSC biology and mechanism of action in cardiac repair of MSC therapy for cardiac disease.作者: 向外才掩飾 時間: 2025-3-22 15:18 作者: 等待 時間: 2025-3-22 19:24 作者: 怎樣才咆哮 時間: 2025-3-23 00:07
Optimal Tissue Sources of Mesenchymal Stromal Cells for Clinical Applications,t every tissue in the body, it has been found that MSC populations retain a “memory of tissue origin” resulting in different functional abilities. This suggests that differences in MSC populations may be important for the development of future MSC therapeutic approaches for tissue and organ repair a作者: immunity 時間: 2025-3-23 04:56 作者: 好忠告人 時間: 2025-3-23 08:08 作者: 光滑 時間: 2025-3-23 11:11 作者: NEEDY 時間: 2025-3-23 15:22 作者: heartburn 時間: 2025-3-23 21:04
D. Chambers,P. Hopkinsaboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Melodrama 時間: 2025-3-24 02:03
Elizabeth Rosado Balmayor,Martijn van Griensvenaboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Keratin 時間: 2025-3-24 02:30 作者: Endemic 時間: 2025-3-24 06:59 作者: 態(tài)度暖昧 時間: 2025-3-24 13:41
Matthew M. Cookaboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Focus-Words 時間: 2025-3-24 18:07
Olle Ringdén M.D., Ph.D.aboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: STAT 時間: 2025-3-24 22:26
Ilse Molendijk,Daan W. Hommes,Marjolijn Duijvesteinaboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: 聾子 時間: 2025-3-24 23:23 作者: 工作 時間: 2025-3-25 07:20 作者: Culmination 時間: 2025-3-25 07:37
Lajos Baranyi,Boro Dropulicaboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: 里程碑 時間: 2025-3-25 13:21
Yunjoon Jung,Jan A. Nolta Ph.D.aboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: 松果 時間: 2025-3-25 15:56 作者: 提升 時間: 2025-3-25 20:52 作者: 膽汁 時間: 2025-3-26 01:28
Anjan K. Das,Pawan K. Gupta,C. H. Anoop,Sudha Balasubramanian,Anish S. Majumdaraboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Apoptosis 時間: 2025-3-26 07:09
Vivek Tanavde,Mohan C. Vemuriaboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Authoritative and practical, .p53 Protocols, Second Edition .seeks to aid scientists in the further study into p53 and other tumor suppressors..978-1-4939-5933-4978-1-62703-236-0Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: recession 時間: 2025-3-26 11:16
tural science has come to be an auxiliary science of rural economics and to become part of the problem. Only when the past role of agricultural science is understood can we reflect on how it can move from being part of the problem to being part of the solution.作者: 淺灘 時間: 2025-3-26 13:25
2196-8985 rom a range of tissue sources.? Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the u978-1-62703-914-7978-1-62703-200-1Series ISSN 2196-8985 Series E-ISSN 2196-8993 作者: 神刊 時間: 2025-3-26 17:26
F. Dos Santos,P. Z. Andrade,C. L. da Silva,J. M. S. Cabral作者: maroon 時間: 2025-3-26 23:45
J. Barminko,A. Gray,T. Maguire,R. Schloss,M. L. Yarmush作者: 蕨類 時間: 2025-3-27 03:18 作者: 舉止粗野的人 時間: 2025-3-27 06:00 作者: 把手 時間: 2025-3-27 11:29 作者: 秘密會議 時間: 2025-3-27 16:37 作者: TSH582 時間: 2025-3-27 20:37 作者: 橫截,橫斷 時間: 2025-3-28 00:21 作者: 銀版照相 時間: 2025-3-28 03:15
Michael R. Doran,Mark Young on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: violate 時間: 2025-3-28 08:56
Matthew M. Cook on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: 沉思的魚 時間: 2025-3-28 12:44
Olle Ringdén M.D., Ph.D. on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: Mawkish 時間: 2025-3-28 16:30 作者: 偽善 時間: 2025-3-28 21:13 作者: 食品室 時間: 2025-3-29 02:15 作者: 開始從未 時間: 2025-3-29 04:34 作者: mortgage 時間: 2025-3-29 07:51
Yunjoon Jung,Jan A. Nolta Ph.D. on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: filicide 時間: 2025-3-29 12:17
Celena Heazlewood,Kerry Atkinson on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: 有毒 時間: 2025-3-29 18:19 作者: gregarious 時間: 2025-3-29 20:51
Anjan K. Das,Pawan K. Gupta,C. H. Anoop,Sudha Balasubramanian,Anish S. Majumdar on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: 濕潤 時間: 2025-3-30 03:58
Vivek Tanavde,Mohan C. Vemuri on troubleshooting and avoiding known pitfalls.Includes sup.The second edition of .p53 Protocols. expands upon the first edition with progress in p53 research since the publication of the first edition. In .p53 Protocols, Second Edition. expert researchers in the field detail many of the methods th作者: 痛得哭了 時間: 2025-3-30 07:41 作者: 圓錐 時間: 2025-3-30 08:12
Mesenchymal Stromal Cell Mechanisms of Immunomodulation and Homing, the potential development of powerful cellular immune therapies, with applications for a variety of inflammatory associated diseases. MSC have the ability to directly abrogate T cell, macrophage, dendritic cell (DC), neutrophil, and B cell pro-inflammatory functions. Specifically, T cell, macrophag作者: Stagger 時間: 2025-3-30 16:11
Mesenchymal Stem Cell Exosomes: The Future MSC-Based Therapy?,ave made mesenchymal stem cells (MSCs) the stem cell of choice for regenerative medicine. Clinical and animal studies have demonstrated that secreted trophic factors, and not stem cell differentiation, likely mediated much of the therapeutic efficacy of MSCs. This paradigm shift in the therapeutic m作者: 輕快來事 時間: 2025-3-30 18:45 作者: 吸氣 時間: 2025-3-30 22:03 作者: 小鹿 時間: 2025-3-31 02:47
Stem Cell Therapy for Bone Disorders,l-known medical conditions like osteoporosis, stem cells are being applied more and more frequently. Furthermore, they are being proposed for the treatment of genetic bone disorders with satisfactory outcomes. However, key questions remain on the type of cell to use, and the isolation and expansion 作者: flourish 時間: 2025-3-31 05:34
Mesenchymal Stem Cell Therapies for Bone and Tendon Conditions, relatively poor healing capabilities, and coupled with their variable response to established medical treatments, produce significant morbidity. Mesenchymal stem cells (MSCs) are capable of regenerating skeletal tissues and therefore offer great promise in the treatment of connective tissue patholo作者: 感染 時間: 2025-3-31 10:11
Mesenchymal Stromal Cells and the Repair of Cartilage Tissue,repair. Whilst a number of surgical techniques have been developed to repair cartilage defects, their efficacy is generally poor and total joint replacement remains the gold standard, albeit last resort, treatment option. Cell-based therapies hold the greatest promise, as they appear uniquely capabl作者: Evacuate 時間: 2025-3-31 14:27
Mesenchymal Stem Cells and Haematopoietic Stem Cell Culture,diseases. However, the limited number of HSC from umbilical cord blood (UCB) limits the efficacy of transplants from this source. This limitation could be overcome by expanding the HSC population prior to transplantation. Although such processes have shown little success to date, it is thought that 作者: 使長胖 時間: 2025-3-31 20:41
Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease and Graft Failure to use mesenchymal stem cells (MSCs) to prevent and treat GVHD and graft failure is due to the ability of MSCs to suppress alloantigen-induced T-cells in vitro. This effect was seen despite HLA-incompatibility between MSC and stimulatory or alloreactive cells in vitro, enabling the potential use of 作者: 不能根除 時間: 2025-3-31 22:53 作者: MOTIF 時間: 2025-4-1 04:15 作者: Palliation 時間: 2025-4-1 07:39 作者: muscle-fibers 時間: 2025-4-1 12:42
